Catalyst Wire Dossier Catalyst Wire Dossier

FOSAPREPITANT

FOSAPREPITANT DIMEGLUMINE · Avenacy, LLC
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for FOSAPREPITANT, covering 2010-02-12 to 2026-08-07. Get the full timeline:

Most recent: FDA Approved: FOSAPREPITANT — Supplemental Application (BE Pharmaceuticals Inc.)

See pricing